| --- | --- | |-------------------------------------------|-------------------------------------| | | | | | | | Q2 FY22 Earnings Presentation May 5, 2022 | | | | | | | Advancing the world of health TM | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage tar ...

Becton, Dickinson and Company (NYSE:BDX) Q2 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Francesca DeMartino - SVP, IR Tom Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP & President, Interventional Segment Conference Call Participants Vijay Kumar - Evercore ISI Travis Steed - Bank of America Robbie Marcus - JPMorgan Lawrence Biegelsen - Wells Fargo Securities Rick Wise - Stifel Operator Hello, and welcome to BD's Earnings Call for the Se ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------|------------------------ ...

Advance every day together Investor Presentation March 7, 2022 Mission To develop and provide solutions that make life better for people living with diabetes Vision A life unlimited by diabetes 1 Forward-looking statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding Embecta Corp.'s ("embecta's") future prospects and performance, including, but not limited to, future revenues, margins, leverage targets, and capital dep ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2022 Earnings Conference Call February 3, 2022 8:30 AM ET Company Participants Francesca DeMartino - SVP, IR Thomas Polen - President, CEO & Chairman Christopher DelOrefice - EVP & CFO Simon Campion - EVP & President, Interventional Segment Conference Call Participants Vijay Kumar - Evercore ISI Robert Marcus - JPMorgan Chase & Co. Matthew Mishan - KeyBanc Capital Markets Lawrence Biegelsen - Wells Fargo Securities Matthew Taylor - UBS Frederick Wise - Stifel, Nic ...

| --- | --- | |------------------------------------------------|-------------------------------------| | | | | | | | Q1 FY22 Earnings Presentation February 3, 2022 | | | | Advancing the world of health TM | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, and earnings per share, leve ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common stock, par value $1.00 BDX New York Stock Exchange Depositary Shares, each representing a 1/20th interest in a share of 6.00% Mandatory Convertible Preferred Stock, Series B BDXB New York Stock Exchange ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-4802 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (Sta ...

Becton, Dickinson and Company (NYSE:BDX) Q4 2021 Earnings Conference Call November 4, 2021 8:00 AM ET Company Participants Nadia Goncalves - SD, IR Tom Polen - Chairman, CEO & President Chris DelOrefice - EVP &CFO Alberto Mas - President, Medical Segment Simon Campion - President, Interventional Segment Dave Hickey - President, Life Sciences Segment Conference Call Participants Vijay Kumar - Evercore ISI Bob Hopkins - Bank of America Robbie Marcus - J.P. Morgan Matthew Mishan - KeyBanc Larry Biegelsen - Wel ...

Becton Dickinson and Company (NYSE:BDX) Q3 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Kristen Stewart – Senior Vice President of Strategy and Investor Relations Tom Polen – Chairman, CEO, and President Chris Reidy – Executive Vice President, CFO, and Chief Administrative Officer Alberto Mas – President of the Medical Segment Simon Campion – President of interventional segments Dave Hickey – President of the Life Sciences segment Conference Call Participants Bob Hopkins – Ba ...